Proposed mechanisms for cancer- and treatment-related cognitive changes.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Seminars in Oncology Nursing

• Publication date

  2013-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.soncn.2013.08.006PMID 24183157PMCID PMC3817493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preliminary Evidence of an Association Between an Interleukin 6 Promoter Polymorphism and Self-Reported Attentional Function in Oncology Patients and Their Family Caregivers

  2014cited by this paper
• Current and emerging technology approaches in genomics.

  2013cited by this paper
• Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?

  2013cited by this paper
• Cytokine genetic variations and fatigue among patients with breast cancer.

  2013cited by this paper
• Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

  2012cited by this paper
• Brain vulnerability to chemotherapy toxicities

  2012cited by this paper
• The attention system of the human brain: 20 years after.

  2012cited by this paper
• Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment

  2012cited by this paper
• Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research

  2012cited by this paper
• Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance

  2012cited by this paper
• Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage

  2012cited by this paper
• Apolipoprotein e sets the stage: response to injury triggers neuropathology.

  2012cited by this paper
• Effects of androgen deprivation on brain function in prostate cancer patients – a prospective observational cohort analysis

  2012cited by this paper
• Androgen deprivation therapy as primary treatment for prostate cancer.

  2012cited by this paper
• Evaluating the Role of Serotonin on Neuropsychological Function After Breast Cancer Using Acute Tryptophan Depletion

  2012cited by this paper
• Cognition in heart failure: An overview of the concepts and their measures

  2011cited by this paper
• Chemotherapy effects on brain glucose metabolism at rest

  2011cited by this paper
• Attention in a Social World

  2011cited by this paper
• Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?

  2011cited by this paper
• Immune system to brain signaling: neuropsychopharmacological implications.

  2011cited by this paper
• An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

  2011cited by this paper
• Differences in Self-reported Attentional Fatigue Between Patients With Breast and Prostate Cancer at the Initiation of Radiation Therapy

  2011cited by this paper
• International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

  2011cited by this paper
• Changes in perceived attentional function in women following breast cancer surgery

  2011cited by this paper
• Catechol‐O‐methyltransferase genotype modulates cancer treatment‐related cognitive deficits in breast cancer survivors

  2011cited by this paper
• Functional polymorphism (5-HTTLPR) in the serotonin transporter gene is associated with subjective well-being: evidence from a US nationally representative sample.

  2011cited by this paper
• The Attentional Function Index—a self‐report cognitive measure

  2011cited by this paper
• Functional polymorphism (5-HTTLPR) in the serotonin transporter gene is associated with subjective well-being: evidence from a US nationally representative sample

  2011cited by this paper
• Allostatic load biomarkers of chronic stress and impact on health and cognition.

  2010cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)

  2010cited by this paper
• Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease

  2010cited by this paper
• Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.

  2010cited by this paper
• Testosterone and the aging male: to treat or not to treat?

  2010cited by this paper
• Understanding vulnerability for depression from a cognitive neuroscience perspective: A reappraisal of attentional factors and a new conceptual framework

  2010cited by this paper
• Role of interleukin‐1β in postoperative cognitive dysfunction

  2010cited by this paper
• Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy.

  2010cited by this paper
• Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

  2009cited by this paper
• Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system.

  2009cited by this paper
• Cognitive Dysfunction and Its Relationship to Quality of Life in Breast Cancer Survivors.

  2009cited by this paper
• The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.

  2008cited by this paper
• Using genetic data in cognitive neuroscience: from growing pains to genuine insights

  2008cited by this paper
• Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

  2008cited by this paper
• Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.

  2008cited by this paper
• Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

  2008cited by this paper
• Cytokines and their relationship to the symptoms and outcome of cancer

  2008cited by this paper
• Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy.

  2008cited by this paper
• Cognitive effects of hormone therapy in men with prostate cancer

  2008cited by this paper
• Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide

  2008cited by this paper
• A Review on

  2008cited by this paper
• Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory

  2008cited by this paper
• Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

  2008cited by this paper
• Attention genes.

  2007cited by this paper
• Candidate mechanisms for chemotherapy-induced cognitive changes

  2007cited by this paper
• Elucidating the relationship between negative affectivity and symptoms: The role of illness-specific affective responses

  2007cited by this paper
• Self-control relies on glucose as a limited energy source: willpower is more than a metaphor.

  2007cited by this paper
• Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues.

  2007cited by this paper
• Adriamycin‐mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain

  2007cited by this paper
• Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?

  2007cited by this paper
• The Strength Model of Self-Control

  2007cited by this paper
• Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies.

  2006cited by this paper
• The molecular genetics of cognition: dopamine, COMT and BDNF

  2006cited by this paper
• Testosterone and cognitive function: current clinical evidence of a relationship.

  2006cited by this paper
• Mitochondrial Oxidative Stress, DNA Damage, and Heart Failure

  2006cited by this paper
• The effect of adjuvant chemotherapy on cognitive functioning in early breast cancer: implications for outcomes research and oncology practice

  2006cited by this paper
• Mitochondriopathy in Parkinson Disease and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo

  2006cited by this paper
• Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity.

  2006cited by this paper
• Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.

  2006cited by this paper
• Testosterone modulates performance on a spatial working memory task in male rats.

  2006cited by this paper
• Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty?

  2006cited by this paper
• Ageing and neuronal vulnerability

  2006cited by this paper
• Adriamycin-induced, TNF-α-mediated central nervous system toxicity

  2006cited by this paper
• Pre‐treatment factors related to cognitive functioning in women newly diagnosed with breast cancer

  2005cited by this paper
• The American Psychiatric Association

  2005cited by this paper
• High-fat diets, insulin resistance and declining cognitive function.

  2005cited by this paper
• Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: Insight into chemobrain

  2005cited by this paper
• Effect of Catechol-O-Methyltransferase val158met Genotype on Attentional Control

  2005cited by this paper
• 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

  2005cited by this paper
• The role of aromatization in testosterone supplementation

  2005cited by this paper
• Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer.

  2004cited by this paper
• Genes and the parsing of cognitive processes.

  2004cited by this paper
• Imaging genetic influences in human brain function.

  2004cited by this paper
• Changes in the human mitochondrial genome after treatment of malignant disease.

  2003cited by this paper
• Gonadal Hormones Affect Spine Synaptic Density in the CA1 Hippocampal Subfield of Male Rats

  2003cited by this paper
• The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy

  2003cited by this paper
• Assessing the molecular genetics of attention networks

  2002cited by this paper
• Diverse actions of ovarian steroids in the serotonin neural system.

  2002cited by this paper
• Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm

  2002cited by this paper
• Chronic stress impairs rotarod performance in rats: implications for depressive state.

  2002cited by this paper
• Serotonin Transporter Genetic Variation and the Response of the Human Amygdala

  2002cited by this paper
• Neural Correlates of Conscious Self-Regulation of Emotion

  2001cited by this paper
• Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review.

  2001cited by this paper
• Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside

  2001cited by this paper
• Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.

  2001cited by this paper
• The role of rumination in depressive disorders and mixed anxiety/depressive symptoms.

  2000cited by this paper
• Pretreatment symptom distress in women newly diagnosed with breast cancer.

  1999cited by this paper
• Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress.

  1999cited by this paper
• Anxiety and directed attention in women awaiting breast cancer surgery.

  1999cited by this paper
• Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

  1998cited by this paper
• Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication.

  1995cited by this paper

• Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database

  2025cites this paper
• Longitudinal Assessment of Cognitive Function in Survivors of Testicular Germ Cell Tumor.

  2024cites this paper
• The impact of novel hormonal agents on fracture risk in prostate cancer patients: a nationwide population-based cohort study

  2024cites this paper
• Seeing through “brain fog”: neuroimaging assessment and imaging biomarkers for cancer-related cognitive impairments

  2024cites this paper
• Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study

  2024cites this paper
• The Relationship between Cancer and Dementia: An Updated Review

  2023cites this paper
• Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia

  2023cites this paper
• Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial

  2023cites this paper
• Processing efficiency in pediatric cancer survivors: A review and operationalization for outcomes research and clinical utility

  2022cites this paper
• Association Between Cardiovascular Disease and Cognitive Dysfunction in Breast Cancer Survivors

  2022cites this paper
• Potential Molecular Biomarkers of Central Nervous System Damage in Breast Cancer Survivors

  2022cites this paper
• Quality of life after treatment with immune checkpoint inhibitors for lung cancer; the impact of age.

  2022cites this paper
• Social Support, social ties, and cognitive function of women with breast cancer: findings from the Women’s Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study

  2022cites this paper
• Long-Term Cognitive Dysfunction in Cancer Survivors

  2021cites this paper
• Caregiver Characteristics Associated With Cognitive Complaints in Women With Breast Cancer.

  2021cites this paper
• A randomized trial of physical activity for cognitive functioning in breast cancer survivors: Rationale and study design of I can! improving cognition after cancer.

  2021cites this paper
• Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways.

  2021cites this paper
• Cognitive Rehabilitation for Cognitive Dysfunction after Cancer and Cancer Treatment: Implications for Nursing Practice.

  2020cites this paper
• Non-pharmacological interventions for cognitive impairment in women with breast cancer post-chemotherapy: A systematic review.

  2020cites this paper
• Understanding the Associations between Caregiver Characteristics and Cognitive Function of Adults with Cancer: A Scoping Review

  2020cites this paper
• Relationship of fatigue with cognitive performance in women with early‐stage breast cancer over 2 years

  2019cites this paper
• Self-Selected Individual Music Therapy for Depression during Hospitalization for Cancer Patients: Randomized Controlled Clinical Trial Study

  2019cites this paper
• A systematic review of the association between fatigue and cognition in chronic noncommunicable diseases

  2019cites this paper
• Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer‐Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy

  2019cites this paper
• Understanding on the association between informal caregiver characteristics and cognitive function of adults with cancer: a scoping review protocol

  2019cites this paper
• Co-occuring symptoms in older oncology patients with distinct attentional function profiles.

  2019cites this paper
• Inotodiol inhibits cells migration and invasion and induces apoptosis via p53-dependent pathway in HeLa cells.

  2019cites this paper
• Breast cancer treatment and its effects on aging.

  2019cites this paper
• Conceptualisation of medication beliefs among patients with advanced cancer receiving oral oncolytic agents using a theory derivation approach

  2019cites this paper
• Impaired brain dopamine transporter in chemobrain patients submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1

  2019cites this paper
• Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28).

  2018cites this paper
• Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review

  2018cites this paper
• Differences in symptom clusters before and twelve months after breast cancer surgery.

  2018cites this paper
• Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer

  2018cites this paper
• Cancer-Related Cognitive Impairment in Breast Cancer Patients: Influences of Psychological Variables

  2018cites this paper
• Perceived Cognitive Changes during Chemotherapy for Breast Cancer : A Longitudinal Pilot Study

  2018influential citation
• Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research.

  2018cites this paper
• Cognitive Changes in Cancer Survivors.

  2018cites this paper
• Electrophysiological biomarkers of chemotherapy-related cognitive impairment in hematological malignancy patients

  2018cites this paper
• The effects of physical activity and fatigue on cognitive performance in breast cancer survivors

  2017cites this paper
• Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy

  2017cites this paper
• Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma

  2017cites this paper
• The Significance of Sleep Disturbance and Attentional Fatigue Among Breast Cancer Survivors

  2017cites this paper
• Measurements of neurotransmitter release in animal models of the central nervous system using fast scan cyclic voltammetry

  2017cites this paper
• Cognitive and Occupational Function in Survivors of Adolescent Cancer

  2017cites this paper
• Effect of β-glucan supplementation on levels of IgM, IgA, IgG and its subclasses IgG1, IgG2, IgG3, and IgG4 in cancer patients

  2016cites this paper
• Neuropsychologische Beeinträchtigungen nach Stammzelltransplantation

  2016cites this paper
• Perceived cognitive changes with chemotherapy for breast cancer: A pilot study.

  2016cites this paper
• Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain

  2016cites this paper
• Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin

  2016cites this paper
• Changes in Cognitive Function Related to Chemotherapy

  2016cites this paper
• The role of the nucleolus in neurodegeneration.

  2016cites this paper
• Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.

  2016cites this paper
• Cognitive Impairment in Breast Cancer Survivors

  2016cites this paper
• Use of complementary therapies for side effect management in breast cancer: evidence and rationale

  2016cites this paper
• Assessment of Cognitive Impairment and Complaints in Individuals With Colorectal Cancer.

  2016cites this paper
• The intersection of cancer and aging: implications for physical activity and cardiorespiratory fitness effects on cognition

  2016cites this paper
• Symptoms: Fatigue and Cognitive Dysfunction.

  2015cites this paper
• Patterns of change in cognitive function with anastrozole therapy

  2015cites this paper
• Cognitive Changes Associated With Cancer and Cancer Treatment: State of the Science

  2015cites this paper
• Patient Education Process in Oncologic Context: What, Why, and by Whom?

  2015cites this paper
• Cognitive changes associated with cancer and cancer treatment: state of the science.

  2015cites this paper
• BREAST CANCER , CIRCADIAN DISRUPTION , MOOD DISORDERS AND SYMPTOMS CLUSTERS Symptom clusters

  2014cites this paper
• Effect of Melatonin on Cognitive Function and Sleep in relation to Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial

  2014cites this paper
• Chronobiology, cognitive function and depressive symptoms in surgical patients.

  2014cites this paper
• Cancer and cognitive changes: the complexity of the problem.

  2013cites this paper